September 27, 2010

The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s acquisition of Seattle-based biotech company ZymoGenetics has expired,...

September 23, 2010

An investigational diabetes drug works as well as a generic already on the market, according...

September 21, 2010

Abbott on Wednesday initiated a proactive, voluntary recall of certain Similac powder infant formulas in...

September 12, 2010

An investigational treatment for HIV by Gilead Sciences that combines four drugs in one tablet...

September 9, 2010

Bristol-Myers Squibb formally has begun its tender offer for biotech company ZymoGenetics, the drug maker...

September 7, 2010

Bristol-Myers Squibb will acquire Seattle-based biotech ZymoGenetics, Bristol said Wednesday....

August 17, 2010

The Food and Drug Administration has agreed to expedite review of an investigational treatment for...

August 10, 2010

The drug market for unipolar depression will get smaller over the next decade due to...

July 21, 2010

An investigational treatment for HIV made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals works as...

June 21, 2010

Cases of the potentially deadly skin cancer melanoma are expected to almost double before the...

June 6, 2010

An investigational drug for skin cancer that had spread to other parts of the body...

May 20, 2010

Data from a late-stage clinical trial of an investigational drug by Boehringer Ingelheim could show...

May 20, 2010

Although Mead Johnson has said it voluntarily will modify or discontinue certain advertising claims for...

May 17, 2010

Charles Hinkaty on Monday was named to the Prestige Brands' board of directors, the company...

May 16, 2010

The cancer drug arm of Eli Lilly plans to show data from more than 50...

March 29, 2010

The U.S. Patent and Trademark Office plans to uphold the patent protection of a blockbuster...

March 16, 2010

The Food and Drug Administration has accepted an approval application for a combination pill for...

March 11, 2010

A popular drug for preventing blood clots may be less effective when taken by a...

March 8, 2010

Two drug makers hope to find out how well a diabetes drug works in treating...

March 7, 2010

Bristol-Myers Squibb has paid Isis Pharmaceuticals a $6 million milestone payment for regulatory approval to...

March 3, 2010

Aims of becoming a leader in biotechnology headlined a meeting Thursday between Bristol-Myers Squibb and...

March 2, 2010

Bristol-Myers Squibb is buying most of the rights to an investigational pain drug for $40...

March 2, 2010

Bristol-Myers Squibb CEO James Cornelius will retire. He will replaced by Lamberto Andreotti, Bristol announced...

March 2, 2010

The Food and Drug Administration has declined to approve a biotech drug for organ transplant...